These findings suggest that BMPs secreted by prostate cancer cells play a role in the induction of osteoblast differentiation and upset the balance of bone remodeling, thus contributing to the osteoblastic phenotype.18 The gene discussed is CLN5; the disease is prostate carcinoma.